According to Cognitive Market Research, the global Medical Shoes market size was USD 10264.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 11.90% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 4105.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 3079.38 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 2360.86 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 513.23 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 205.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.6% from 2024 to 2031.
The diabetic shoes category is the fastest growing segment of the Medical Shoes industry
